SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-079409
Filing Date
2017-03-13
Accepted
2017-03-13 06:06:02
Documents
3
Period of Report
2017-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256844d8k.htm 8-K 15118
2 EX-10.1 d256844dex101.htm EX-10.1 100945
3 GRAPHIC g256844g0310115017901.jpg GRAPHIC 3898
  Complete submission text file 0001193125-17-079409.txt   122983
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36828 | Film No.: 17683810
SIC: 2834 Pharmaceutical Preparations